Hamzeh Alipour

Shiraz University of Medical Sciences, Shiraz, Iran

Ehab Atallah

*Section Head, hematological malignancies, Medical College of Wisconsin, Milwaukee, WI, USA

Pedro Barata

*Tulane Medical School Department of Internal Medicine, New Orleans, Louisiana,USA.

Antonio Facchiano

Istituto Dermopatico dell’Immacolata (IDI-IRCCS), Rome, Italy

Shilpa Gupta

*Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio

Vadim Koshkin

*Division of Hematology and Oncology, University of California San Francisco

John L. Marshall

Chief, Division of Hematology/Oncology, Medstar Georgetown University Hospital, Washington DC, USA

Disis Mary L. (Nora)

Director, Cancer Vaccine Institute, University of Washington (UW), Seattle, WA, USA

Jianyu Rao

UCLA Medical Center, Santa Monica, LA, USA

Giuseppe Saglio

*Division of Internal Medicine and Haematology, University of Turin, Turin, Italy

David S.Hong

Associate Vice President of Clinical Research, University of Texas M.D. Anderson Cancer Center

Kendra Sweet

*Department of Malignant Hematology H. Lee Moffitt Cancer Center Tampa, FL, USA

Eugene V Koonin

National Institutes of Health, Bethesda, MD, USA

Jorge A. Garcia

*Oncology University Hospitals Seidman Cancer Center, Cleveland, OH, USA.

Jonathan A. Kelber

Department of Biology, California State University Northridge (CSUN), Los Angeles, California

Asseel Alregib

School of Medicine, Taylor’s University, Subang Jaya, Malaysia

Sanja Aveic

RWTH Aachen University Hospital, Dental Materials and Biomaterials Research, Aachen, Germany

Basak Bahcivanci

College of Medical & Dental Sciences, University of Birmingham, Birmingham , UK

Armando Bartolazzi

Department of Pathology, Sant’Andrea University Hospital, Rome, Italy

Iris Car

University of Rijeka, Department of Biotechnology, Rijeka, Croatia

Bruna Corradetti

Houston Methodist Research Institute, Houston, USA

Mads Daugaard

Department of Urologic Sciences, University of British Columbia, Vancouver, Canada

Silvia De Francia

Department of Clinical and Biological Sciences, University of Turin, Orbassano (TO), Italy

Marzia Del Re

Unit of Clinical Pharmacology and Pharmacogenetics, Azienda Ospedaliero-Universitaria Pisana, Pisa

Zoran Gatalica

The University of Oklahoma Health Sciences Center, Oklahoma City, USA

Pier Giorgio Natali

Ex. Scientific Director, Regina Elena Institute (IRE), Rome, Italy

Julie Goodwin

Yale School of Medicine, New Haven, CT, USA

Francesca Granucci

Department of Biotechnology and Biosciences, University of Milano-Bicocca, Milan, Italy

Cara Haymaker

Director, (ORION), UT MD Anderson Cancer Center, Houston, TX, US

Elisabeth Heath

*Karmanos Cancer Institute, Wayne State School of Medicine, Detroit, Michigan.

Licia Iacoviello

IRCCS Neuromed, Pozzilli & University of Insubria Varese, Italy

Astero Klampatsa

Thoracic Oncology Immunotherapy Group, The Institute of Cancer Research, London, UK

Francisco La Rosa

University of Colorado, AMC Department of Pathology, Aurora, CO, US

Leena Latonen

School of Medicine, Institute of Biomedicine, University of Eastern Finland, Kuopio, Finland

Michael Levin

Tufts University, Medford, USA.

Jing Li

Universitat Autònoma de Barcelona, Barcelona, Spain

Ye-Lin Liang

Sun Yat-sen University Cancer center, Guangzhou, China

Dario Longo

Institute of Biostructures and Bioimaging (IBB), Italian National Research Council, Torino, Italy

Gerry Melino

Faculty of Medicine, University of Rome – Tor Vergata, Rome, Italy

Cristina M. Failla

Experimental Immunology Laboratory, IDI-IRCCS, Rome, Italy

Moonsoo M. Jin

Director, Molecular Imaging Innovations Institute (MI3), Weill Cornell Medicine, NY, USA

Andreas Pircher

Medizinische Universität Innsbruck, Innsbruck, Austria

Leana Rich M. Herrera

Polytechnic University of the Philippines, Philippines

Yufang Shi

Soochow University Institutes for Translational Medicine, China

Maria João Sousa

Oncology Institute of Coimbra, Coimbra, Portugal

Y-h. Taguchi

Department of Physics, Chuo University, Tokyo, Japan

Che-Kai Tsao

Medical Director, Ruttenberg Treatment Center, Tisch Cancer Institute, Mount Sinai Hospital, NY, USA

Qian Xie

Quillen College of Medicine, East Tennessee State University, Johnson City, US

Wong Yin How

School of Medicine, Faculty of Health & Medical Sciences, Taylor's University, Subang Jaya, Malaysia

Panos Z. Anastasiadis

Cell Biology Program Director, Mayo Clinic Cancer Center, Jacksonville, FL, USA